Natalie Yivgi Ohana, PhD, is a life science entrepreneur, Scientific founder and CEO of Minovia Therapeutics Ltd. Led the company since incorporation in 2011; Holds a Ph.D. in Biochemistry from the Hebrew University; Postdoctoral fellowship at the Weizmann Institute; Twenty+ years experience in mitochondrial research that led to the development of a novel mitochondrial cell therapy approach to treat mitochondrial diseases: from ideation to clinical stage; from a small start up to a global organization with a team of Biotech leaders. Raised $27M from private investors; established collaborations with top researchers and clinical centers around the world, as well as strategic partnership with a leading pharma company.